News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
North Annette
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
4
| North Annette (EVP & General Counsel) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 669 shares
@ $36.3, valued at
$24.3k
Granted 16,283 shares
@ $0
Granted 58,600 options to buy
@ $37.68, valued at
$2.2M
|
|
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| North Annette (EVP, General Counsel & Secty.) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 6,483 shares
@ $0
Granted 29,175 options to buy
@ $140.01, valued at
$4.1M
|
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2020 |
4
| North Annette (EVP, General Counsel & Secty.) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 56,000 options to buy
@ $63.33, valued at
$3.5M
|
|
| 04/16/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/24/2019 |
4
| North Annette (SVP, General Counsel) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 100,000 options to buy
@ $15.47, valued at
$1.5M
|
|
| 01/26/2018 |
4
| North Annette (SVP, General Counsel) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 70,000 options to buy
@ $20, valued at
$1.4M
|
|
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|